The medical research increasingly goes hand in hand with thetechnological innovation, and almost every area of healthcare is linked to the development of new technologies. The skin care: i-Tech Industries, a Bologna-based company active for years in the development of non-invasive connective tissue treatment technologies, has created a device capable of intervening in the post-surgical aesthetic-functional rehabilitation also in the field oncology, at treatment of lymphatic and vascular problems, as well as in the event of scars and burns: icoone Medical is one therapeutic tool highly innovative, harnessing the potential of microstimulation in the service of medicine.

icoone offers a treatment that can prepare the tissue prior to a surgical operation, draining and softening the skin; at the same time, in the post-operative reduces healing time and alleviates pain. Tissue oxygenation reduces fibrosis caused by surgeries o radiation in the treatment of breast cancer, minimising problems such as erythema, pain and skin hardening: microstimulation improves the skin’s flexibility and elasticity, reducing oedema with both aesthetic and functional benefits. It also enables the treatment of lymphatic problems, scars, burns, vascular problems, intestinal problems, accelerating tissue regeneration; it alleviates the muscle pain, awakens the neurosensory system, reoxygenates muscle tissue, gives support to theathletic activity, It reduces inflammation – both traumatic and non-traumatic – of the aponeurosis and tendons. Icoone treatments can be used to complement other treatments or therapies to speed up the recovery process, and the customisable settings of the handpieces allow for a treatment tailored to the patient, which effectively addresses specific issues.

By virtue of the potential of the new icoone® devices in the field of oncology, i-Tech Industries signed a partnership with IrisRoma xwomen xlife Onlus, an organisation operating throughout the country to protect women’s health, through early diagnosis, and in fight against cancer and their prevention. Through this association, the devices will be given to the Department of Clinical Oncology at the Policlinico Campus Bio Medico in Rome. Cancer patients can thus benefit from icoone treatments through the alveolar microstimulation for the post-surgical aesthetic-functional rehabilitation, the treatment of lymphoedema, the post-radiation burns and any intervention deemed useful to support the patient.